The homepage of Geekvape's official website has announced that French football club Paris Saint-Germain has once again partnered with Geekvape.
In 2021, Geekvape became the official partner of Paris Saint-Germain. The football club stated that this partnership embodies the spirit of geekiness by presenting exciting matches that attract a wide range of international viewers.
Allen Yang, CEO of Shenzhen Kickna Technology Co. Ltd., stated, "I am delighted with the success of our partnership last year and honored to continue promoting a healthy sporting spirit alongside Paris Saint-Germain in the new year. We share a common philosophy of striving for excellence and elegance and look forward to an exciting new season.
sponsorship by Geekvape
Geekvape is expanding the reach of sports marketing and pushing the vaping industry to new heights by partnering with one of the world's most successful and prestigious soccer clubs. By using soccer as a widely popular sport, Geekvape aims to spread the passion for sports and a healthy lifestyle to people worldwide. "Geekvape's partnership with Paris Saint-Germain aligns perfectly with our company's mission," said Geekvape CEO Yang Tingwang. World-class soccer players such as Lionel Messi, Kylian Mbappé, and Neymar Jr. play for Paris Saint-Germain. The club expressed that their optimistic sports attitude and desire to push themselves to the limits align with Geekvape's spirit.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
